New Ruthenium Complexes for the Treatment of Cancer
- 1 January 1989
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Synthesis, molecular structure, and tumor-inhibiting properties of imidazolium trans-bis(imidazole)tetrachlororuthenate(III) and its methyl-substituted derivativesInorganic Chemistry, 1987
- Comparative antitumor activity of ruthenium derivatives with 5?-deoxy-5-fluorouridine in chemically induced colorectal tumors in SD ratsCancer Chemotherapy and Pharmacology, 1987
- Synthesis, antitumor activity, and x-ray structure of bis(imidazolium) (imidazole)pentachlororuthenate(III), (ImH)2(RuImCl5)Inorganic Chemistry, 1987
- 4 Platinum Antitumour AgentsProgress in Medicinal Chemistry, 1987
- Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III)Zeitschrift für Krebsforschung und Klinische Onkologie, 1986
- Spirogermanium: A new investigational drug of novel structure and lack of bone marrow toxicityInvestigational New Drugs, 1983
- 264 - Redox Reactions and Antitumor Activity of Tetra-μ-Carboxylatodirhodium(II)Bioelectrochemistry and Bioenergetics, 1978
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969
- New ruthenium carboxylate complexesJournal of Inorganic and Nuclear Chemistry, 1966
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965